Adar Poonawalla, the chief executive of Serum Institute of India, said his company may sell Covishield, the Covid-19 vaccine being developed by Oxford University, for around Rs 500-600 per shot.
from Hindustan Times - india https://ift.tt/390LLWS
Home / Hindustan Times - india
/ Covid-19 vaccine update: Covaxin phase 3 trials to begin in Haryana today, minister...
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment